Estates Ltd Wilmslow serves as Executive at HISTOGENICS CORP, where they oversee executive responsibilities. Since joining the company, Estates Ltd Wilmslow has executed 12 insider transactions totaling $4.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 8, 2019 involved exercising options for 1,244,444 shares valued at $0.
Estates Ltd Wilmslow currently holds 5,258,859 shares of HISTOGENICS CORP (HSGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Estates Ltd Wilmslow has been a net buyer of HSGX stock. They have purchased $4.3M and sold $8.7K worth of shares.
Estates Ltd Wilmslow's most recent insider trade was on Feb 8, 2019, when they sold 1,244,444 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 403,845 |
| $N/A |
| Discretionary |
| Oct 10, 2018 | HSGX | $0 | Purchase | 538,460 | $N/A | Discretionary |
| Dec 2, 2016 | HSGX | $0 | Conversion | 996,779 | $N/A | Discretionary |
| Sep 29, 2016 | HSGX | $557.2K | Award | 247,665 | $2.25 | Discretionary |
| Jun 1, 2015 | HSGX | $0 | Other | 89,441 | $N/A | Discretionary |
| Dec 8, 2014 | HSGX | $4.3M | Purchase | 394,918 | $11.00 | Discretionary |
| Dec 8, 2014 | HSGX | $8.7K | Sale | 792 | $11.00 | Discretionary |
| Dec 8, 2014 | HSGX | $0 | Other | 17,383 | $N/A | Discretionary |
| Dec 8, 2014 | HSGX | $0 | Conversion | 492,618 | $N/A | Discretionary |
| Dec 8, 2014 | HSGX | $0 | Conversion | 747,000 | $N/A | Discretionary |
| Dec 8, 2014 | HSGX | $8.7K | Exercise | 11,502 | $0.76 | Discretionary |